Gary S. Jacob

CEO & Chief Scientific Officer at Callisto Pharmaceuticals

Gary S. Jacob, Ph.D. has served as Chief Executive Officer and Chief Scientific Officer since May 2003, and Chairman of Synergy Pharmaceuticals Inc. since October 2003. Dr. Jacob formerly served as Chief Scientific Officer of Synergy Pharmaceuticals Inc. from 1999 to 2003. From 1990 to 1998, Dr. Jacob served as a Monsanto Science Fellow, specializing in the field of Glycobiology. From 1997 to 1998, Dr. Jacob was Director of Functional Genomics, Corporate Science & Technology, Monsanto. From 1990 to 1997, Dr. Jacob was Director of Glycobiology, G.D. Searle Pharmaceuticals Inc. From 1986 to 1990, Dr. Jacob was Manager of the G.D. Searle Glycobiology Group located at Oxford University, England. Dr. Jacob received his Ph.D. in biochemistry from the University of Wisconsin-Madison, and his Bachelor of Science degree (with honors) in chemistry from the University of Missouri – St. Louis.

Links

Timeline

  • CEO & Chief Scientific Officer

    Current role